Covea Insurance

This week: More questions than answers

This week started out with more questions than answers as Prime Minister Boris Johnson announced his plans to 'actively encourage' those who hadn't been able to go to work through the lockdown back into the workplace albeit with some heavy caveats.

Covéa pulls out of $9bn Partner Re deal

Covéa has scrapped its $9bn (£7.3bn) buy of Bermuda-based global reinsurer Partner Re from the Ferrari-owning Agnelli family’s holding company Exor less than two years after if failed to takeover reinsurer Scor.

This week: Under pressure

UK insurers are coming under increased scrutiny as Covid-19 worsens. And this week that was certainly the case for Hiscox after businesses threatened the insurer with a class action lawsuit for rejecting claims related to the Covid-19 outbreak.

Insurer gender pay gaps shrink slightly

Insurers’ gender pay gaps narrowed marginally in 2019, with the difference between the median and mean pay of women and men shrinking by 0.94% and 1.46% respectively among a sample of top insurers collated by Post.

Analysis: Where does Covid-19 leave the flood victims?

Storms Ciara and Dennis hit the UK in early February and a little over six weeks later Prime Minister Boris Johnson put the country in effective lockdown after the Covid-19 virus was declared a pandemic by the World Health Organisation. Stephanie Denton,…

Analysis: A coronavirus call centre crisis?

Personal lines insurance providers are faced with a potentially “lethal” situation if call centre staff cannot go into work en masse due to coronavirus disruption, compliance experts have cautioned. Post asked brokers and insurers how they are preparing…

Covéa agrees $9bn deal for Partner Re

Covéa has signed up to buy Bermuda-based global reinsurer Partner Re from the Ferrari-owning Agnelli family for $9bn (£7bn) in cash in a deal scheduled to complete in the fourth quarter of this year.

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here